3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Prostatic Neoplasms
18
Neoplasms
9
Colonic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Breast Neoplasms
6
Uterine Cervical Neoplasms
4
Colorectal Neoplasms
4
Uterine Cervical Dysplasia
3
Urinary Bladder Neoplasms
3
Mouth Neoplasms
3
Esophageal Neoplasms
3
Carcinoma, Hepatocellular
3
Thyroid Nodule
2
Thyroid Neoplasms
2
Thrombocythemia, Essential
2
Testicular Neoplasms
2
Rectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Polycythemia Vera
2
Oropharyngeal Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Liver Neoplasms
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Hodgkin Disease
2
Glioma
2
Gallbladder Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Basal Cell
2
Interventions
Propranolol
2
daratumumab
1
Watchful Waiting
1
Surgical Procedures, Operative
1
Simvastatin
1
Observation
1
DNA
1
Atorvastatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hemangioma, Cavernous, Central Nervous System
×
Watchful Waiting
×
Clear all
NCT04467489
2025-08-11
Biomarkers of CASH
University of Chicago
Active not recruiting
1,040 enrolled